Abstract Purpose of Review In spite of recent advances in treatment, many people with
multiple sclerosis (MS) require ongoing care and support. Informal caregivers can …

Neuropsychiatric abnormalities may be broadly divided in two categories: disorders of
mood, affect, and behavior and abnormalities affecting cognition. Among these conditions …

Multiple sclerosis (MS) produces demyelination and degeneration in both gray and white
matter. Both cortical and deep gray matter injury is observed during the course of MS …

Background and Objectives: The COVID-19 pandemic required the adoption of new
technologies to improve access to healthcare at an unprecedented speed, as social …

Background and purpose Data from neuro‐imaging techniques allow us to estimate a
brain's age. Brain age is easily interpretable as 'how old the brain looks' and could therefore …

Neurocognitive impairment (NCI) is one of the most relevant clinical manifestations of
multiple sclerosis (MS). The profile of NCI and the structural and functional changes in the …

Multiple sclerosis (MS) is a demyelinating disease of autoimmune originate. A large
proportion of patient present with cognitive deficits that negatively affect their quality of life …

Objective Over the last few decades clinicians have become aware that cognitive
impairment might be a major cause of disability, loss of employment and poor quality of life …

Background and Purpose Cognitive impairment (CI) is a common symptom of multiple
sclerosis (MS). Although demographic and clinical factors contribute to MS-dependent CI …

Background While cognitive deficits in memory and processing speed have been well-
documented in individuals with multiple sclerosis (MS), language is largely considered to be …